Endocrine Testing Market Share, Opportunities, Industry 2030
Endocrine Testing Market Share, Opportunities, Industry 2030
Segments - Endocrine Testing Market by Test Types (Estradiol Test, Follicle Stimulating Hormone Test, Human Chorionic Gonadotropin Hormone Test, Luteinizing Hormone Test, Dehydroepiandrosterone Sulfate Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone Test, Prolactin Test, Cortisol Test, Insulin Test, and Others), Technology (Tandem Mass Spectrometry, Immunoassay Technology, Monoclonal & Polyclonal Antibody Technology, Sensor Technology, Clinical Chemistry Technology, and Others), End-users (Hospital, Commercial Laboratory, Ambulatory Care Centers, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, And Forecast 2021 – 2028
Upcoming
| Report ID :HC-984
| 4.4 Rating
| 76 Reviews
| 143 Pages
| Format :
Report Description
The global endocrine testing market size is projected to expand at a substantial CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to the rising endocrine disorders such as adrenal insufficiency and hyperthyroidism.
Endocrine systems consist of several glands that produce secrete hormones circulating in the human body. These hormones regulate several body functions such as growth and development, homeostasis, metabolism, stimulus response, and reproduction. Pituitary gland, pancreas, thyroid, hypothalamus, and adrenal glands are parts of the endocrine system. Secretion of hormones in these glands are used for various biochemical processes in the human body.
The endocrine test is primarily conducted to determine the concentrations of endocrine hormones in the human body such as insulin, estradiol, cortisol DHEA-S, testosterone, luteinizing, follicle stimulating hormone, human chorionic gonadotropin, and progesterone. The symptoms of an endocrine disorder vary and depends on particular gland while some common symptoms can be feeling lethargic, weak, or fatigued.
Technological advancements such as launch of easy-to-operate test kits have enabled the penetration of home-based diagnosis, which are cost effective and user friendly. Furthermore, aging population is the target of the market because of rising susceptibility to chronic diseases and huge risk of complications at the elder age that requires continuous health monitoring.
Market Trends, Drivers, Restraints, and Opportunities
- Growing prevalence of endocrine disorders and chronic illness such as diabetes and obesity are major factors responsible for fueling the market growth during the forecast period.
- Increasing consciousness about health and growing awareness of benefits regarding endocrine diagnostics among people are anticipated to drive the market expansion.
- Rising geriatric population and favorable government initiatives encouraging the development of new diagnostics kits are projected to boost the growth of the market in the coming years.
- High cost for the technology development and lack of skilled professionals to carry out endocrine testing procedure are key challenges that can restrain the market growth.
- Ongoing R&D activities and technological advancement to improve diagnostic techniques and methods for better and effective treatment are offering major opportunities for the market expansion.
Scope of the Report
The report on the global endocrine testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Endocrine Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Test Types (Estradiol Test, Follicle Stimulating Hormone Test, Human Chorionic Gonadotropin Hormone Test, Luteinizing Hormone Test, Dehydroepiandrosterone Sulfate Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone Test, Prolactin Test, Cortisol Test, Insulin Test, and Others), Technology (Tandem Mass Spectrometry, Immunoassay Technology, Monoclonal & Polyclonal Antibody Technology, Sensor Technology, Clinical Chemistry Technology, and Others), and End-users (Hospital, Commercial Laboratory, Ambulatory Care Centers, and Others) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, bioMerieux SA, Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche, LabCorp, and Quest Diagnostics |
Market Segment Insights
Thyroid stimulating hormone test segment to account for a key share
Based on test types, the global endocrine testing market is divided into estradiol test (E2), follicle stimulating hormone test (FSH), human chorionic gonadotropin hormone test (hCG), luteinizing hormone test (LH), dehydroepiandrosterone sulfate test (DHEAS), progesterone test, testosterone test, thyroid stimulating hormone test (TSH), prolactin test, cortisol test, insulin test, and others. The TSH test segment held a large market share in 2020 and is expected to account for a key revenue share in the coming years owing to rising disorders related to TSH and increasing awareness for relation between different levels of thyroid hormones cardiovascular disorders. However, the insulin test segment is expected to register a rapid growth rate during the forecast period. Growing number of the diabetic population and increasing awareness of several diagnosis are projected to increase demand for insulin tests. This is projected to boost the segment during the forecast period.
Sensor segment is expected to grow at a rapid pace
In terms of technology, the market is segmented into tandem mass spectrometry, immunoassay technology, monoclonal & polyclonal antibody technology, sensor technology, clinical chemistry technology and others. The tandem mass spectrometry is projected to expand at a substantial CAGR during the forecast period. The segment growth is attributed to increasing use of liquid chromatography combining with tandem mass spectrometry that aid to overcome challenges related to traditional techniques used in the testing. On the other hand, the sensor segment is projected to grow at a rapid pace as compared to all other segments because of increasing use of biosensors for diabetes in glucose monitoring, which is primarily used by patients to check their blood sugar level on a daily basis.
Hospital segment to hold a large market share
On the basis of end-users, the global endocrine testing market is divided into hospital, commercial laboratory, ambulatory care centers, and others. The hospital segment is anticipated to hold a large market share during the forecast period owing to wide availability of skilled professionals and advanced infrastructure in hospitals. Moreover, high adoption of innovative testing devices in hospitals as compared to others such as clinics act as a key driver for the segment growth.
Asia Pacific region to register a high CAGR
Based on regions, the global endocrine testing market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to expand at an impressive CAGR during the forecast period owing to well-establishment of the primary, secondary, and tertiary care hospitals along with increasing awareness about use of advanced technologies among people.
The market of Asia-Pacific, however, is expected to exhibit a rapid growth rate in the coming years owing to key factors such as increasing expenditure on R&D by private agencies and government for improving diagnosis in the region. Constructive government initiatives for reimbursement policies and healthcare infrastructure in emerging economies such as China, India, and Japan are projected to drive the regional market growth.
Segments
Segments Covered in the ReportThe global endocrine testing market has been segmented on the basis of
Test Types
- Estradiol Test
- Follicle Stimulating Hormone Test
- Human Chorionic Gonadotropin Hormone Test
- Luteinizing Hormone Test
- Dehydroepiandrosterone Sulfate Test
- Progesterone Test
- Testosterone Test
- Thyroid Stimulating Hormone Test
- Prolactin Test
- Cortisol Test
- Insulin Test
- Others
- Tandem Mass Spectrometry
- Immunoassay Technology
- Monoclonal & Polyclonal Antibody Technology
- Sensor Technology
- Clinical Chemistry Technology
- Others
- Hospital
- Commercial Laboratory
- Ambulatory Care Centers
- Others
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Abbott Laboratories
- AB Sciex
- Agilent Technologies
- Biomedical Technologies
- bioMerieux SA
- Bio Rad Laboratories
- DiaSorin
- Hoffmann-La Roche
- LabCorp
- Quest Diagnostics
Competitive Landscape
Some of the key players competing in the global endocrine testing market include Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, bioMerieux SA, Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, and Quest Diagnostics.
Many players are concentrating on strategic initiatives such as mergers and acquisitions, co-development deals, product launches and development, and licensing partnerships to increase their products portfolio. Moreover, these competitors are focusing on strategies such as introducing technological advanced products and collaboration to sustain in the competition.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Endocrine Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Endocrine Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Endocrine Testing Market - Supply Chain
4.5. Global Endocrine Testing Market Forecast
4.5.1. Endocrine Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Endocrine Testing Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Endocrine Testing Market Absolute $ Opportunity
5. Global Endocrine Testing Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Endocrine Testing Market Size and Volume Forecast by Types
5.3.1. Estradiol Test
5.3.2. Follicle Stimulating Hormone Test
5.3.3. Human Chorionic Gonadotropin Hormone Test
5.3.4. Luteinizing Hormone Test
5.3.5. Dehydroepiandrosterone Sulfate Test
5.3.6. Progesterone Test
5.3.7. Testosterone Test
5.3.8.
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Endocrine Testing Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Endocrine Testing Market Size and Volume Forecast by End Users
6.3.1. Hospital
6.3.2. Commercial Laboratory
6.3.3. Ambulatory Care Centers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Endocrine Testing Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Endocrine Testing Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Endocrine Testing Demand Share Forecast, 2019-2026
8. North America Endocrine Testing Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Endocrine Testing Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Endocrine Testing Market Size and Volume Forecast by Types
8.4.1. Estradiol Test
8.4.2. Follicle Stimulating Hormone Test
8.4.3. Human Chorionic Gonadotropin Hormone Test
8.4.4. Luteinizing Hormone Test
8.4.5. Dehydroepiandrosterone Sulfate Test
8.4.6. Progesterone Test
8.4.7. Testosterone Test
8.4.8.
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Endocrine Testing Market Size and Volume Forecast by End Users
8.7.1. Hospital
8.7.2. Commercial Laboratory
8.7.3. Ambulatory Care Centers
8.7.4. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Endocrine Testing Demand Share Forecast, 2019-2026
9. Latin America Endocrine Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Endocrine Testing Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Endocrine Testing Market Size and Volume Forecast by Types
9.4.1. Estradiol Test
9.4.2. Follicle Stimulating Hormone Test
9.4.3. Human Chorionic Gonadotropin Hormone Test
9.4.4. Luteinizing Hormone Test
9.4.5. Dehydroepiandrosterone Sulfate Test
9.4.6. Progesterone Test
9.4.7. Testosterone Test
9.4.8.
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Endocrine Testing Market Size and Volume Forecast by End Users
9.7.1. Hospital
9.7.2. Commercial Laboratory
9.7.3. Ambulatory Care Centers
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Endocrine Testing Demand Share Forecast, 2019-2026
10. Europe Endocrine Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Endocrine Testing Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Endocrine Testing Market Size and Volume Forecast by Types
10.4.1. Estradiol Test
10.4.2. Follicle Stimulating Hormone Test
10.4.3. Human Chorionic Gonadotropin Hormone Test
10.4.4. Luteinizing Hormone Test
10.4.5. Dehydroepiandrosterone Sulfate Test
10.4.6. Progesterone Test
10.4.7. Testosterone Test
10.4.8.
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Endocrine Testing Market Size and Volume Forecast by End Users
10.7.1. Hospital
10.7.2. Commercial Laboratory
10.7.3. Ambulatory Care Centers
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Endocrine Testing Demand Share Forecast, 2019-2026
11. Asia Pacific Endocrine Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Endocrine Testing Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Endocrine Testing Market Size and Volume Forecast by Types
11.4.1. Estradiol Test
11.4.2. Follicle Stimulating Hormone Test
11.4.3. Human Chorionic Gonadotropin Hormone Test
11.4.4. Luteinizing Hormone Test
11.4.5. Dehydroepiandrosterone Sulfate Test
11.4.6. Progesterone Test
11.4.7. Testosterone Test
11.4.8.
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Endocrine Testing Market Size and Volume Forecast by End Users
11.7.1. Hospital
11.7.2. Commercial Laboratory
11.7.3. Ambulatory Care Centers
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Endocrine Testing Demand Share Forecast, 2019-2026
12. Middle East & Africa Endocrine Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Endocrine Testing Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Endocrine Testing Market Size and Volume Forecast by Types
12.4.1. Estradiol Test
12.4.2. Follicle Stimulating Hormone Test
12.4.3. Human Chorionic Gonadotropin Hormone Test
12.4.4. Luteinizing Hormone Test
12.4.5. Dehydroepiandrosterone Sulfate Test
12.4.6. Progesterone Test
12.4.7. Testosterone Test
12.4.8.
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Endocrine Testing Market Size and Volume Forecast by End Users
12.7.1. Hospital
12.7.2. Commercial Laboratory
12.7.3. Ambulatory Care Centers
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Endocrine Testing Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Endocrine Testing Market: Market Share Analysis
13.2. Endocrine Testing Distributors and Customers
13.3. Endocrine Testing Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Abbott Laboratories
13.4.2. AB Sciex
13.4.3. Agilent Technologies
13.4.4. Biomedical Technologies
13.4.5. bioMerieux SA
13.4.6. Bio Rad Laboratories
13.4.7. DiaSorin
13.4.8. Hoffmann-La Roche
13.4.9.
Methodology
Related Reports
Some other reports from this category!
Our Clients
